EX-10.19(A) 10 d535851dex1019a.htm EX-10.19(A) [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted...Exclusive License Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionThis License Agreement (“Agreement”) is made as is made as of the 28th day of June, 2013 (the “Effective Date”) by and between the Mayo Foundation for Medical Education and Research, having its principal place of business at 200 First Street SW, Rochester, MN 55905 (“Mayo”), and Cenexys, Inc., a Delaware corporation, having a place of business at 1700 Owens St., Suite 535, San Francisco, CA 94158 (“Company”).
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • April 23rd, 2018 • Unity Biotechnology, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 23rd, 2018 Company Industry JurisdictionThis License Agreement (“Agreement”) is made as is made as of the 28th day of June, 2013 (the “Effective Date”) by and between the Mayo Foundation for Medical Education and Research, having its principal place of business at 200 First Street SW, Rochester, MN 55905 (“Mayo”), and Cenexys, Inc., a Delaware corporation, having a place of business at 1700 Owens St., Suite 535, San Francisco, CA 94158 (“Company”).